Novel Terephthalic Acid‐Based Schiff Bases: Synthesis, Biological Evaluation, Molecular Docking, and DFT Studies
Chemistry & Biodiversity · 2026-11 · 23 (11)
DOI: 10.1002/cbdv.71930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 16.11.2026. Verfasst von Kerem Buran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey. Hauptthemen laut MEDLINE: Phthalic Acids, Molecular Docking Simulation, Density Functional Theory, Antioxidants. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Terephthalic acid‐based Schiff bases have attracted considerable attention owing to their diverse biological activities and potential pharmaceutical applications. In this study, four novel terephthalic acid‐based Schiff base derivatives were synthesized and characterized by FT‐IR, 1 H NMR, 13 C NMR, and MALDI‐TOF/MS analyses. The compounds were evaluated for antioxidant, antimicrobial, and enzyme inhibitory activities. Compound 2 exhibited the strongest antioxidant activity and inhibitory effects against tyrosinase (IC 50 : 0.83 ± 0.01 mg/mL) and α‐amylase (IC 50 : 0.67 ± 0.03 mg/mL). In contrast, α‐glucosidase inhibition was observed only for compounds 1, 3, and 4 (IC 50 : 1.01 ± 0.01 mg/mL). Antimicrobial studies revealed generally weak activity against bacteria and yeasts, with moderate effects against A. baumannii , P. aeruginosa , and C. parapsilosis (MIC: 500–700 µg/mL). Molecular docking indicated favorable interactions with the investigated enzymes, particularly α‐glucosidase, while density functional theory (DFT) calculations provided insights into electronic properties and chemical reactivity. Overall, compound 2 showed the most favorable biological performance, whereas compound 4 exhibited the best docking profile. These findings support terephthalic acid‐based Schiff bases as scaffolds for further structural optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
- Experimental Medicine Application & Research Center, Validebağ Research Park, University of Health Sciences, Istanbul, Turkey.
- Department of Pharmaceutical Chemistry, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkey.
- Opticianry Program, Hamidiye Vocational School of Health Services, University of Health Sciences, Istanbul, Turkey.
- Department of Pharmaceutical Microbiology, Hamidiye Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
- Department of Phytotherapy, Hamidiye Institute of Health Sciences, University of Health Science, Istanbul, Turkey.
ORCID-Profile: Kerem Buran, Elmas Rumeysa Yıldırım, Nazmiye Öner, Derya Doğanay, Esra Mertoğlu, Abdullahi Ibrahim Uba, Gokhan Zengin
Zitieren
APA
Buran, K., Yıldırım, E. R., Öner, N., Doğanay, D., Mertoğlu, E., Uba, A. I., & Zengin, G. (2026). Novel Terephthalic Acid‐Based Schiff Bases: Synthesis, Biological Evaluation, Molecular Docking, and DFT Studies. Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71930
Vancouver
Buran K, Yıldırım ER, Öner N, Doğanay D, Mertoğlu E, Uba AI, et al. Novel Terephthalic Acid‐Based Schiff Bases: Synthesis, Biological Evaluation, Molecular Docking, and DFT Studies. Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71930
BibTeX
@article{Buran2026,
author = {Buran, Kerem and Yıldırım, Elmas Rumeysa and Öner, Nazmiye and Doğanay, Derya and Mertoğlu, Esra and Uba, Abdullahi Ibrahim and Zengin, Gokhan},
title = {Novel Terephthalic Acid‐Based Schiff Bases: Synthesis, Biological Evaluation, Molecular Docking, and DFT Studies},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {11},
doi = {10.1002/cbdv.71930}
}
EUVIMED